Westpac Banking Corp bought a new position in Ventas, Inc. (NYSE:VTR – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 101,045 shares of the real estate investment trust’s stock, valued at approximately $8,973,000.
Other hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in Ventas by 3.2% in the fourth quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock valued at $5,876,856,000 after buying an additional 2,349,176 shares in the last quarter. BlackRock Inc. bought a new stake in Ventas during the second quarter worth about $4,953,439,000. State Street Corp increased its holdings in shares of Ventas by 2.5% during the fourth quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after buying an additional 735,620 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of Ventas by 3.8% during the fourth quarter. Geode Capital Management LLC now owns 12,988,943 shares of the real estate investment trust’s stock worth $1,001,447,000 after buying an additional 475,633 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in shares of Ventas by 27.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock worth $710,060,000 after buying an additional 2,000,341 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.
Ventas Trading Up 0.7%
Shares of NYSE VTR opened at $93.32 on Friday. Ventas, Inc. has a 1-year low of $66.38 and a 1-year high of $101.60. The company has a market cap of $47.87 billion, a PE ratio of 172.81, a P/E/G ratio of 2.14 and a beta of 0.69. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The company has a 50-day moving average of $91.36 and a two-hundred day moving average of $87.08.
Insider Buying and Selling at Ventas
In other news, Director Michael J. Embler purchased 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average price of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.53% of the stock is currently owned by insiders.
Analyst Ratings Changes
Several research analysts have recently commented on the company. KeyCorp boosted their target price on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. BMO Capital Markets raised their price target on Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a report on Tuesday, August 11th. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, July 21st. Wells Fargo & Company boosted their price objective on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, June 1st. Finally, Raymond James Financial assumed coverage on Ventas in a report on Tuesday, June 16th. They set an “outperform” rating and a $94.00 target price on the stock. Fifteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, Ventas currently has an average rating of “Moderate Buy” and an average target price of $98.00.
Check Out Our Latest Stock Report on VTR
Ventas Company Profile
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
